BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7817343)

  • 1. Persistent low plasma levels of HIV-1 in patients on AZT therapy and its implications.
    Camsonne R; Bustany P; Bigot MC; Pottier D; Moulin MA
    Therapie; 1994; 49(2):146-7. PubMed ID: 7817343
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy.
    Burke DS; Redfield RR; Bjornson DC; Fowler AK; Oster CN
    N Engl J Med; 1989 Dec; 321(24):1682. PubMed ID: 2586573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 4. Education needed after AZT failure.
    Nurs Stand; 1993 Apr 7-13; 7(29):6. PubMed ID: 8499278
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
    Kaulen P; Pham DT; Baranowski E; Wollensak J
    Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of various biological markers in HIV 1 infection].
    Serra JE; Pombo V; Côrte-Real R; da Cunha S; Meliço-Silvestre A
    Acta Med Port; 1993 Jan; 6(1):5-9. PubMed ID: 8097351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term observation on children. HIV-positive pregnant women: AZT therapy to be continued].
    Gürtler L
    Fortschr Med; 1999 Mar; 117(8):6. PubMed ID: 10220949
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
    Tamalet C; Puel J; Fleury H; Ferchal F; Agut H; Brun-Vezinet F; Botti G; Rouzioux C
    Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron status and mortality in HIV infection.
    Weinberg GA
    Haematologica; 2006 Jun; 91(6):721. PubMed ID: 16769564
    [No Abstract]   [Full Text] [Related]  

  • 12. [AZT therapy. Success in HIV-infected children].
    Marcus U
    Fortschr Med; 1989 Jan; 107(3):9-10. PubMed ID: 2920990
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effectiveness of zidovudine].
    Mulder JW
    Ned Tijdschr Geneeskd; 1995 Feb; 139(5):211-3. PubMed ID: 7854480
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
    Eron JJ; Smeaton LM; Fiscus SA; Gulick RM; Currier JS; Lennox JL; D'Aquila RT; Rogers MD; Tung R; Murphy RL
    J Infect Dis; 2000 May; 181(5):1622-8. PubMed ID: 10783117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZT and asymptomatic HIV infection.
    Van Demark RE
    S D J Med; 1989 Oct; 42(10):9. PubMed ID: 2595355
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy for HIV-1-related nephritis with zidovudine.
    Harrer T; Hunzelmann N; Stoll R; Baur A; Kalden JR
    AIDS; 1990 Aug; 4(8):815-7. PubMed ID: 2261137
    [No Abstract]   [Full Text] [Related]  

  • 17. Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
    Lefaucheur JP; Authier FJ; Verroust J; Gherardi RK
    Muscle Nerve; 1997 Jan; 20(1):106-9. PubMed ID: 8995592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic monitoring of azidothymidine (AZT)].
    Camsonne R; Bazin C; Moulin MA; Fusibet H; Bigot MC
    Therapie; 1989; 44(6):417-8. PubMed ID: 2623657
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemophilia nurses ask to be warned.
    Nurs Stand; 1993 Apr 14-20; 7(30):7. PubMed ID: 8499294
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
    Jackson JB
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.